Evidence map›Paper›PMID 36982917›Full record

ArticleInternational journal of molecular sciences2023

Investigating the Functional Roles of Aldehyde Dehydrogenase 3A1 in Human Corneal Epithelial Cells.

Georgia-Persephoni Voulgaridou, Vasileios Theologidis, Maria Venetikidou, Ilias Tsochantaridis, Avgi Tsolou, Maria Koffa, Mihalis I Panayiotidis, Aglaia Pappa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Mechanisms of Protection Against Oxidative Stress During Hibernation.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Corneal strain influences keratocyte proliferation and migration through upregulation of ALDH3A1 expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  9. Targeting the glutamine-arginine-proline metabolism axis in cancer.Journal of enzyme inhibition and medicinal chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Georgia-Persephoni VoulgaridouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-0173-8560
Vasileios TheologidisDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Maria VenetikidouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Ilias TsochantaridisDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-1607-7470
Avgi TsolouDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-0139-019X
Maria KoffaDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-2255-3426
Mihalis I PanayiotidisDepartment of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus.ORCID 0000-0002-1450-3552
Aglaia PappaDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-0913-4315
Democritus University of Thrace · GRCyprus Institute of Neurology and Genetics · CY

Funding

"Competitiveness, Entrepreneurship & Innovation" (EPAnEK), co-funded by European Regional Development Fund (ERDF) and national resources InTechThrace (MIS code 5047285)
6 · The paper itself

Abstract

Aldehyde dehydrogenase 3A1 (ALDH3A1) oxidizes medium-chain aldehydes to their corresponding carboxylic acids. It is expressed at high rates in the human cornea, where it has been characterized as a multi-functional protein displaying various cytoprotective modes of action. Previous studies identified its association with the DNA damage response (DDR) pathway. Here, we utilized a stable transfected HCE-2 (human corneal epithelium) cell line expressing ALDH3A1, to investigate the molecular mechanisms underlying the cytoprotective role(s) of ALDH3A1. Our data revealed morphological differences among the ALDH3A1-expressing and the mock-transfected HCE-2 cells accompanied by differential expression of

Indexed as

Aldehyde DehydrogenaseHydrogen PeroxideCorneaDieldrinEpithelial CellsHumansAldehyde DehydrogenaseDieldrinHCEHydrogen Peroxidealdehyde dehydrogenase 3A1antioxidantcell cycle regulationcorneacorneal epitheliumcorneal homeostasisDNA damageDNA damage responsenuclear localizationoxidative stresswound healing

Identifiers

PMID36982917
PMCPMC10056195
OpenAlexW4327961127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.